Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
European Commission Approves Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer Patients Not Candidates for PD-(l)1 Inhibitors
Wednesday, June 24, 2026Gilead Sciences Inc Nasdaq GILD today announced that the European Commission EC has granted marketing authorization for Trodelvy sacituzumab govitecanhziy as monotherapy for the treatment of adult
Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus
Wednesday, June 24, 2026Enanta Pharmaceuticals Inc NASDAQENTA a clinicalstage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that the European
Vitalant Launches New Analytical Capabilities in Pittsburgh Lab Expansion as Part of National CGT Strategy
Tuesday, June 23, 2026Vitalant one of the nations largest nonprofit blood and biotherapies healthcare organizations today announces the launch of expanded testing capabilities within the Vitalant Coagulation Laboratory in Pittsburgh
Pheno Therapeutics Granted FDA IND Clearance for Lead Multiple Sclerosis Therapeutic Candidate PTD802
Tuesday, June 23, 2026Pheno Therapeutics Limited Pheno a clinical stage biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases today announced
Rewriting Cancer returns for second film series produced for UICC by BBC StoryWorks
Tuesday, June 23, 2026The Union for International Cancer Control UICC is pleased to present the second series of Rewriting Cancer featuring films that explore the changing face of cancer around the world
Brooks Instrument Launches Ultra-Compact, High-Performance Mass Flow Controller
Monday, June 22, 2026Brooks Instrument a world leader in precision fluid measurement and control technology announced the global launch of its new ultracompact AMF Series Advanced Mass Flow Controller About the size of a standard Postit Note pad it has the smallest footp...
Voro Therapeutics and Alloy Therapeutics Enter Strategic Research Collaboration to Advance Next-Generation Masked T-Cell Engager Therapeutics
Friday, June 19, 2026Voro Therapeutics a biotechnology company developing tumoractivated biologics designed to improve the therapeutic index of immune therapies and Alloy Therapeutics a biotechnology ecosystem company dedicated
IQure Pharma Awarded Grant from The Michael J. Fox Foundation to Advance EAAT2 Program in Parkinson's Disease
Friday, June 19, 2026IQure Pharma a clinicalstage biotech company developing firstinclass astrocytetargeted therapies designed to restore glutamate balance in CNS disorders today announced it has been awarded a research grant from The Michael
LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody
Thursday, June 18, 2026LabGenius Therapeutics LabGenius a drug discovery company combining machine learning ML and highthroughput experimentation to optimise therapeutic antibodies today announced a multiyear research collaboration option and
Protillion Biosciences Announces Drug Discovery Collaboration with Merck
Wednesday, June 17, 2026Protillion Biosciences Inc a leader in labintheloop AI drug design today announced the signing of a multitarget discovery collaboration and license agreement with Merck known as MSD outside the United States and Canada
